Hormones and heart disease in women: Where are we in 2005? Elizabeth Barrett-Connor Invited Commentary Pages: 85 - 87
The good fat hormone: Adiponectin and cardiovascular disease Dat DoJorge AlvarezRobert Chilton OriginalPaper Pages: 94 - 99
Homocysteine: Role and implications in atherosclerosis Sasidhar GuthikondaWilliam G. Haynes OriginalPaper Pages: 100 - 106
Triglycerides and remnant particles as risk factors for coronary artery disease Takamitsu NakamuraKiyotaka Kugiyama OriginalPaper Pages: 107 - 110
Behavioral cardiology: Recognizing and addressing the profound impact of psychosocial stress on cardiovascular health Sajal DasJames H. O’Keefe OriginalPaper Pages: 111 - 118
Cardiac allograft vasculopathy: The achilles’ heel of long-term survival after cardiac transplantation Amandeep DhaliwalVinay Thohan OriginalPaper Pages: 119 - 130
Imaging of atherosclerosis using magnetic resonance: State of the art and future directions Milind Y. DesaiJoão A. C. Lima OriginalPaper Pages: 131 - 139
Optical coherence tomography and its use in detection of vulnerable plaque Mehmet CilingirogluKerem Ozer OriginalPaper Pages: 140 - 143
Adiposopathy is a more rational treatment target for metabolic disease than obesity alone Harold BaysCarlos A. Dujovne OriginalPaper Pages: 144 - 156
Optimal low-density lipoprotein levels: Evidence from epidemiology and clinical trials Josh ToddJohn A. Farmer OriginalPaper Pages: 157 - 162
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases Laura CalabresiCesare R. SirtoriGuido Franceschini OriginalPaper Pages: 163 - 167